HAS2 and cancer: Besides, transcription factor FOS and PBX1 have been reported to be indicators of the activation of ER (Cheung et al., 2005; Toska et al., 2017), we then carried out studies to determine the function of these transcription factors and mechanism of HAS2 in triggering resistance in cancer cells through the regulation of ER-dependent transcriptional response.